- Half Year 2024 Healius Ltd Earnings Call TranscriptFeb 27, 2024A$1.27 (-8.66%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 28, 2023
- Healius Ltd Conference Call TranscriptNov 22, 2023
- Full Year 2023 Healius Ltd Earnings Call TranscriptAug 30, 2023A$2.7 (+7.75%)Earnings
- Australian Clinical Labs Ltd To Merge with Healius Ltd Call TranscriptMar 19, 2023
- Half Year 2023 Healius Ltd Earnings Call TranscriptFeb 27, 2023A$2.6 (-4.10%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptOct 20, 2022
- Full Year 2022 Healius Ltd Earnings Call TranscriptAug 30, 2022A$3.54 (+3.51%)Earnings
- Half Year 2022 Healius Ltd Earnings Call TranscriptFeb 23, 2022A$4.08 (+5.25%)Earnings
- Healius Ltd to Acquire Agilex Biolabs Pty Ltd Call TranscriptDec 17, 2021
- Full Year 2021 Healius Ltd Earnings Call TranscriptAug 30, 2021A$4.32 (-7.34%)Earnings
- Half Year 2021 Healius Ltd Earnings Call TranscriptFeb 24, 2021A$3.69 (+2.31%)Earnings
- Healius Ltd Sustainable Improvements Program and Capital Management Plans Call TranscriptDec 08, 2020
- Healius Ltd Annual Shareholders Meeting TranscriptOct 22, 2020
- Full Year 2020 Healius Ltd Earnings Call TranscriptAug 21, 2020A$3.04 (+0.31%)Earnings
- Healius Ltd Sales of Medical Centres and Market Update Presentation TranscriptJun 15, 2020
- Half Year 2020 Healius Ltd Earnings Call TranscriptFeb 26, 2020A$2.94 (+15.22%)Earnings
- Healius Ltd Annual Shareholders Meeting TranscriptNov 24, 2019
- Full Year 2019 Healius Ltd Earnings Call TranscriptAug 16, 2019A$2.71 (+5.02%)Earnings
Full Year 2019 Healius Ltd Earnings Call Transcript
Good morning, everybody. Janet Payne here. Welcome to Healius' Financial Year 2019 Results. I have with me in the room, of course, Dr. Malcolm Parmenter, our CEO and MD. I also have Mark Ellis here, who is our General Manager of Finance.
We will start off, of course, with Malcolm doing a short presentation on the -- a short speech on the presentation that we launched today.
Malcolm, over to you.
Thanks, Janet. Hello, everybody. Thanks for joining our full year results call today. Now before I start into the detail, I think I'd like to say at the outset, contrary to frequent media speculation, I can confirm we're not selling anything, not Pathology, not Imaging, not IVF, not anything else.
So look, I've spoken before about our 3 main businesses: Pathology, Medical Centres and Imaging; and our 3 emerging businesses; dental, IVF and day hospitals, and about how we have a clear strategy to deliver growth.
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)